Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia.

Schizophr Bull · 2022 · PMC9077422 · PMID 35211743

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Different from the previous trial in which statistical significance for the primary endpoint was reached for both 64 mg/mg and 32 mg/day 20 this trial did not reach statistical significance on the primary endpoint.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.